KNF Knife Riv Q4 2025 EPS beats consensus estimates by 332 percent as shares climb 19 percent amid upbeat investor reaction Sana Biotechnology SANA Stock Should You Consider Buying Q4 2025 Profit Disappoints Amgen Inc AMGN Joins FDA RealTime Clinical Trial Pilot as Peer Pharma Pipeline Moves Signal Sector Growth Trajectory What is WiMi WIMI DCF valuation Extends Gains 20260427 KIDS OrthoPediatrics posts wider than expected Q4 2025 loss shares edge 012 lower in daily trading Woori WF Quarter Start Woori posts 554 EPS miss falling short of consensus targets EVI Industries EVI gains 072 percent in todays trade despite Q1 2026 EPS missing analyst consensus estimates Is Monarch MCRI stock a buy or hold Slight Downtick 20260501